Navellier & Associates Inc. boosted its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 136.0% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 4,620 shares of the enterprise software provider's stock after buying an additional 2,662 shares during the period. Navellier & Associates Inc.'s holdings in Oracle were worth $690,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. FMR LLC raised its holdings in Oracle by 0.4% during the 4th quarter. FMR LLC now owns 38,002,902 shares of the enterprise software provider's stock valued at $6,332,803,000 after buying an additional 156,269 shares during the period. Geode Capital Management LLC raised its holdings in Oracle by 1.8% during the 4th quarter. Geode Capital Management LLC now owns 35,814,302 shares of the enterprise software provider's stock valued at $5,954,961,000 after buying an additional 619,619 shares during the period. Franklin Resources Inc. raised its holdings in Oracle by 9.3% during the 4th quarter. Franklin Resources Inc. now owns 20,202,421 shares of the enterprise software provider's stock valued at $3,366,531,000 after buying an additional 1,722,037 shares during the period. Northern Trust Corp raised its holdings in Oracle by 12.5% during the 4th quarter. Northern Trust Corp now owns 19,620,534 shares of the enterprise software provider's stock valued at $3,269,566,000 after buying an additional 2,176,892 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Oracle by 20.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after buying an additional 2,350,448 shares during the period. Hedge funds and other institutional investors own 42.44% of the company's stock.
Oracle Price Performance
Shares of NYSE ORCL opened at $245.05 on Friday. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The company has a market cap of $688.31 billion, a PE ratio of 56.46, a P/E/G ratio of 3.62 and a beta of 1.39. The business has a 50-day simple moving average of $204.42 and a two-hundred day simple moving average of $171.59. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $251.60.
Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.06. The business had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The company's quarterly revenue was up 11.3% on a year-over-year basis. During the same quarter last year, the company earned $1.63 earnings per share. As a group, equities analysts expect that Oracle Corporation will post 5 EPS for the current fiscal year.
Oracle Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, July 24th. Investors of record on Thursday, July 10th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date of this dividend was Thursday, July 10th. Oracle's dividend payout ratio (DPR) is 46.08%.
Insider Activity
In other news, Director Rona Alison Fairhead bought 480 shares of the firm's stock in a transaction that occurred on Monday, July 7th. The stock was purchased at an average price of $233.87 per share, with a total value of $112,257.60. Following the completion of the acquisition, the director directly owned 22,110 shares of the company's stock, valued at $5,170,865.70. This trade represents a 2.22% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Clayton M. Magouyrk sold 15,000 shares of Oracle stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $214.10, for a total value of $3,211,500.00. Following the sale, the insider directly owned 60,722 shares of the company's stock, valued at $13,000,580.20. This trade represents a 19.81% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 448,669 shares of company stock valued at $85,555,309. 42.20% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the company. BMO Capital Markets increased their target price on Oracle from $235.00 to $245.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 2nd. DA Davidson increased their target price on Oracle from $140.00 to $170.00 and gave the stock a "neutral" rating in a research note on Thursday, June 12th. Royal Bank Of Canada increased their target price on Oracle from $145.00 to $195.00 and gave the stock a "sector perform" rating in a research note on Thursday, June 12th. Raymond James Financial reiterated a "strong-buy" rating on shares of Oracle in a research note on Wednesday, June 18th. Finally, TD Cowen increased their target price on Oracle from $250.00 to $275.00 and gave the stock a "buy" rating in a research note on Thursday, July 3rd. Nine analysts have rated the stock with a hold rating, twenty-three have given a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $218.29.
View Our Latest Stock Report on Oracle
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report